Literature DB >> 9129148

Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts.

A Martin1, P A Duffy, C Liossis, A Gomez-Muñoz, L O'Brien, J C Stone, D N Brindley.   

Abstract

Concentrations of the bioactive lipids, phosphatidate and diacylglycerol, increased with time in culture in ras- and tyrosine kinase (fps)-transformed fibroblasts but not in control fibroblasts. On Day 3, diacylglycerol and phosphatidate concentrations were about 3.3- and 5.5-fold higher respectively in the ras-transformed compared to control fibroblasts. These concentrations in fps-transformed fibroblasts were increased about twofold. The changes in phosphatidate and diacylglycerol resulted from enhanced phospholipid turnover rather than from synthesis de novo. The increased ratio of phosphatidate to diacylglycerol is explained by decreased activities of two distinct phosphatidate phosphohydrolases and increased diacylglycerol kinase in ras-transformed fibroblasts. Ceramide concentrations were about 2.5- and threefold higher in the fps- and ras-transformed cells respectively on Day 3 compared to the controls. Incubating control fibroblasts from Days 1 to 3 with phosphatidylcholine-specific phospholipase C increased diacylglycerol, phosphatidate and ceramide concentrations, and decreased Mg2+-independent-phosphatidate phosphohydrolase activity. 8-(4-chlorophenylthio)-cAMP had a cytostatic effect in ras-transformed cells, it decreased the concentrations of phosphatidate and diacylglycerol, but increased that of ceramide. The consequences of increased ceramide and phosphatidate concentrations in ras-transformed cells are discussed in relation to signal transduction, cell division and the transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129148     DOI: 10.1038/sj.onc.1200987

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.

Authors:  S M Dudek; S M Camp; E T Chiang; P A Singleton; P V Usatyuk; Y Zhao; V Natarajan; J G N Garcia
Journal:  Cell Signal       Date:  2007-04-06       Impact factor: 4.315

2.  Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice.

Authors:  Bernard P C Kok; Petra C Kienesberger; Jason R B Dyck; David N Brindley
Journal:  J Lipid Res       Date:  2011-11-05       Impact factor: 5.922

3.  Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.

Authors:  Yutong Zhao; Satish K Kalari; Peter V Usatyuk; Irina Gorshkova; Donghong He; Tonya Watkins; David N Brindley; Chaode Sun; Robert Bittman; Joe G N Garcia; Evgeni V Berdyshev; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

4.  KSR stimulates Raf-1 activity in a kinase-independent manner.

Authors:  N R Michaud; M Therrien; A Cacace; L C Edsall; S Spiegel; G M Rubin; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters.

Authors:  R Jasinska; Q X Zhang; C Pilquil; I Singh; J Xu; J Dewald; D A Dillon; L G Berthiaume; G M Carman; D W Waggoner; D N Brindley
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

6.  Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility.

Authors:  S Cutrupi; G Baldanzi; D Gramaglia; A Maffè; D Schaap; E Giraudo; W van Blitterswijk; F Bussolino; P M Comoglio; A Graziani
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Differential regulation of the expressions of the PGC-1α splice variants, lipins, and PPARα in heart compared to liver.

Authors:  Bernard P C Kok; Jason R B Dyck; Thurl E Harris; David N Brindley
Journal:  J Lipid Res       Date:  2013-03-16       Impact factor: 5.922

8.  FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.

Authors:  Sandra Pereira; Edward Park; Yusaku Mori; C Andrew Haber; Ping Han; Toyoyoshi Uchida; Laura Stavar; Andrei I Oprescu; Khajag Koulajian; Alexander Ivovic; Zhiwen Yu; Deling Li; Thomas A Bowman; Jay Dewald; Jamel El-Benna; David N Brindley; Roger Gutierrez-Juarez; Tony K T Lam; Sonia M Najjar; Robert A McKay; Sanjay Bhanot; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-13       Impact factor: 4.310

Review 9.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

10.  A mechanism for suppression of the CDP-choline pathway during apoptosis.

Authors:  Craig C Morton; Adam J Aitchison; Karsten Gehrig; Neale D Ridgway
Journal:  J Lipid Res       Date:  2013-10-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.